Best Medicines Coalition / Coalition pour de meilleurs médicaments
Registration:
4
of
34
(2020-05-07
to
2020-06-08)
Legislative Proposal, Bill or Resolution
- Provide feedback on Bill C-213, the Canada Pharmacare Act.
- Share patient group perspectives on national pharmacare proposals (follow-up from the Health Committee's report and the ongoing work of the Advisory Council on the Implementation of National Pharmacare).
Policies or Program
- Ensure patient organizations are consulted during the proposed creation of the Canadian Drug Agency as outlined in Budget 2019.
- Provide feedback on Budget 2019's proposal for a national strategy for high-cost drugs for rare diseases.
- Provide feedback on the Government of Canada's response to COVID-19 to address the potential exacerbation of drug shortages.
Policies or Program, Regulation
- Discuss Canada's response to the proposed bulk importation of medications from Canada to the United States
- Recommend that the government and regulators adopt proactive approaches to communicating drug supply and shortages issues and measures to address them.
- Recommend that the new powers for the Health Minister in the Food and Drug Act governing drug supplies should be extended past their September 2020 expiry date and be made permanent.
- Share patient group perspectives on drug pricing issues, specifically regulations and guidelines related to the Patented Medicines Prices Review Board.
Regulation
- Communicate perspectives regarding the 30-day limit on prescription refills.
- Request to delay implementation of the federal PMPRB regulations in light of the COVID-19 pandemic allowing all stakeholders to focus efforts on dealing with the public health emergency.